Michael Klichinsky, Chief Scientific Officer at Carisma Therapeutics Inc. (CARM), sold 484,347 shares at $0.25 ($124K) on 2025-10-02, disclosed to the SEC on 2025-10-03.
Open-market sale of $124k CARM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 165,000 | $43K | 34.6% |
| 2 | $0.25 | 200,000 | $50K | 40.3% |
| 3 | $0.26 | 119,347 | $31K | 25.0% |
| Total | $0.26 avg | 484,347 | $124K | 100% |